LGND Bathi mangsa ngarep Ligand Pharmaceuticals Incorporated

Simbol resmi perusahaan Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals (LGND) relies on an asset-light patent ownership model, yet external political conflicts complicate the global licensing of its technologies. The company's profit trajectory reflects the influence of these factors, where the value of 0.24 records the metric level. The protection of Captisol and stringent FDA requirements ensure business stability, creating an insurmountable barrier to entry for new market players.

ligand.com (LGND): Bathi resik sing dikarepake saka 04.07.2022 nganti 18.11.2026

Ligand Pharma - rincian analitis lan metrik utama (LGND)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:LGND, Ligand
Produk dadi Ligand Pharmaceuticals Incorporated

This indicator synthesizes discounted future cash flows per share, filtering out market noise to identify the business's intrinsic value. For Ligand Pharmaceuticals (LGND), the extrapolation of future earnings depends directly on the commercial success of partner drugs and the high margins of the Captisol platform, converting expected royalties into a concrete financial vector for long-term capital growth.

Analisis pesaing Ligand Pharmaceuticals

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Amneal Pharmaceuticals, Inc. AMRX|Perrigo (PRGO) - Bathi resik sing dikarepake|ALVO: Bathi mangsa ngarep|Liquidia - Bathi resik mangsa ngarep|GLPG: Proyeksi bathi mangsa ngarep|ANI Pharma - Penghasilan resik sing dikarepake|MNKD (MannKind Corp) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake amphastar.com AMPH|Bathi sing dikarepake Pacira BioSciences, Inc. (PCRX)|SPRY (ARS Pharmaceuticals, Inc.) - Penghasilan resik sing dikarepake|Theravance Biopharma, Inc. - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Aquestive Corp AQST|scPharmaceuticals - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Bathi sing dikarepake|SXTC - Prakiraan bathi perusahaan|Bathi sing dikarepake eupraxiapharma.com|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan